TomoTherapy optimizes radiation therapy by delivering an advanced form of Intensity Modulated Radiation Therapy (IMRT) with unprecedented precision. This enables more accurate and more precise treatment of the tumor, while minimizing the dose to surrounding healthy tissue.
What’s unique about this technology is that a limited CT scan is taken prior to each daily treatment to best determine the precise location of a patient’s tumor. Radiation is then targeted and delivered to the specific area via tiny highly targeted beams that rotate in a helical pattern.
“Valley’s Radiation Oncologists are among the most experienced in the Northeast in the use of this cutting-edge technology, which allows us to deliver precision radiation therapy, “ explains Michael F. Wesson, M.D., Radiation Oncologist. “This technology reduces exposure of healthy tissue to radiation, which means a reduction in side effects for our patients.”
During a patient’s course of treatment, which can take up to nine weeks, a tumor can move and change in size. The ability to do 3-D CT imaging immediately before each treatment to verify the exact location of a tumor increases the precision of the treatment. “We are now able to perform Image Guided Radiation Therapy (IGRT), which is the new state-of-the-art for radiation therapy treatment,” says Chad DeYoung, M.D., Director of Radiation Oncology.
The Valley Hospital Department of Radiation Oncology has a long and proud track record of innovation. Valley was the first institution on the East Coast to perform prostate seed implant therapy and the first to treat patients using Intensity Modulated Radiation Therapy (IMRT).
The Valley Hospital Oncology Services Program became the first in New Jersey and the New York metropolitan area to be awarded Disease-Specific Care Certification for cancer care from The Joint Commission (TJC). This certification serves as the Gold Seal of Approval™ for health care quality.